BDBM703963 (S)-5-amino-N-((5-bromopyridin- 2-yl)methyl)-6-methyl-N-(1- (pyrimidin-2-yl)ethyl)-1H- pyrrolo[3,2-b]pyridine-2- carboxamide LCMS [M + 1]+ = 468.0. 1H NMR (400 MHz, DMSO-d6) $#948; = 11.66- 11.05 (m, 1H), 9.02-8.50 (m, 3H), 8.14-7.86 (m, 1H), 7.68- 7.13 (m, 3H), 6.73-6.00 (m, 1H), 5.34 (br s, 2H), 5.07-4.36 (m, 1H), 2.13 (br s, 3H), 1.72-1.52 (m, 3H)::US20240368153, Example 10-1
SMILES Cc1cc2[nH]c(C(=O)N(Cc3ccc(Br)cn3)[C@H](C)c3ncccn3)cc2nc1N
InChI Key InChIKey=JKULQMNXTLIXNY-UHFFFAOYSA-N
Data 2 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 703963
TargetProtein arginine N-methyltransferase 5 (PRMT5) and Methylosome protein WDR77 (MEP-50)(Human)
Mirati Therapeutics
US Patent
Mirati Therapeutics
US Patent
Affinity DataIC50: 9.07E+3nMAssay Description:Table B2: The assay uses recombinant full-length histone H2A as the PRMT5 substrate. Enzymatic transfer of the tritiated methyl group from S-adenosyl...More data for this Ligand-Target Pair
TargetProtein arginine N-methyltransferase 5 (PRMT5) and Methylosome protein WDR77 (MEP-50)(Human)
Mirati Therapeutics
US Patent
Mirati Therapeutics
US Patent
Affinity DataIC50: 9.07E+3nMAssay Description:Table B2: The assay uses recombinant full-length histone H2A as the PRMT5 substrate. Enzymatic transfer of the tritiated methyl group from S-adenosyl...More data for this Ligand-Target Pair
